HLA Typing – B5 (PCR)
د.إ1,250.00Sample Type : Whole Blood
Methodology : Real-time PCR
TAT : 10 Days
Showing 19–27 of 32 results
Sample Type : Whole Blood
Methodology : Real-time PCR
TAT : 10 Days
The Jak 2 Exon 12-15 Mutation Analysis is a specialized genetic test designed to detect mutations in exons 12-15 of the JAK2 gene, which are associated with myeloproliferative neoplasms (MPNs) such as polycythemia vera (PV) and other hematologic disorders. This test offers high sensitivity and specificity, enabling early and accurate diagnosis, which is crucial for targeted treatment decisions and disease monitoring. Unlike standard JAK2 V617F mutation tests, this analysis identifies rare but clinically significant mutations, providing comprehensive genetic profiling for patients with suspected MPNs. Its advanced molecular technology ensures reliable results, supporting personalized therapeutic strategies and improving patient outcomes.
The Life Geno-DNA Based Comprehensive Wellness Screening Panel is an advanced genetic testing solution that analyzes your DNA to provide personalized insights into your overall health, wellness, and disease risk. Key features include in-depth analysis of genetic markers related to nutrition, fitness, metabolism, sleep, stress, and predisposition to chronic conditions.
Mitochondrial DNA (mtDNA) Sequencing provides high-resolution analysis of mitochondrial genomes, enabling precise identification of genetic variations. Key features include full-length mtDNA sequencing, high accuracy, and deep coverage, ensuring reliable detection of mutations and heteroplasmy. Benefits include applications in ancestry research, forensic identification, disease association studies, and evolutionary biology.
The MTHFR Mutation (C677T) Analysis is a genetic test that identifies the presence of the C677T variant in the MTHFR gene, which can impact folate metabolism and homocysteine levels. Key features include accurate DNA analysis using a simple saliva or cheek swab sample, fast turnaround time, and clear, actionable results. Benefits include personalized insights into potential health risks such as cardiovascular issues, fertility challenges, and neurological conditions, enabling targeted lifestyle and nutritional interventions. Its unique selling point lies in empowering individuals with genetic knowledge to make informed health decisions and optimize wellness through precision nutrition.
The Oncomine Acute Myeloid Leukaemia (AML) Panel is a targeted next-generation sequencing (NGS) assay designed for comprehensive genomic profiling of AML. It enables simultaneous detection of key mutations, gene fusions, and copy number variations across clinically relevant genes associated with AML.
The Oncomine Comprehensive Myeloid/Leukemia Panel (DNA + RNA fusions) is a next-generation sequencing (NGS) assay designed for comprehensive genomic profiling of myeloid malignancies and leukemias. It simultaneously analyzes DNA and RNA to detect key mutations, copy number variations, and gene fusions across a broad range of clinically relevant genes.
The Oncomine Myeloproliferative Neoplasm (MPN) Panel is a targeted next-generation sequencing (NGS) assay designed for the comprehensive detection of key driver mutations in myeloproliferative neoplasms. It enables the simultaneous analysis of JAK2, CALR, and MPL genes, which are critical for MPN diagnosis and classification. The panel offers high sensitivity, detecting low-frequency variants with as little as 10 ng of input RNA or DNA, making it ideal for limited or degraded samples.
Panorama Extended Prenatal Screening is a cutting-edge, non-invasive prenatal test (NIPT) designed to provide expectant parents with critical insights into their baby’s health.
Sample Type : Maternal blood
Methodology : PCR-single nucleotide polymorphism (SNP)-based technology
TAT : 10 Days